Form 4 for DTIL PRECISION BIOSCIENCES INC
Accepted 2024-01-23 00:00:00 ET · period of report 2024-01-20 · accession 0001209191-24-002121 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-23 | 2024-01-20 | DTIL | Kelly John Alexander | CFO | M - OptEx | — | +116.7K | 614.2K | +23% | — |
| D | 2024-01-23 | 2024-01-20 | DTIL | Kelly John Alexander | CFO | M - OptEx | $0.00 | -116.7K | 233.3K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-20 | M | A | 116,690 | — | 614,169 | D | — | — | (F1) Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2024. (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. |
| 2 | Derivative | Restricted Stock Units | 2024-01-20 | M | D | 116,690 | $0.00 | 233,310 | D | — · — to — | 116,690 Common Stock | (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. (F3) On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. |